A Study of the Safety and Efficacy of CMX001 for the Prevention of CMV Infection in CMV-seropositive HCT Recipients
Clinical trial NCT01769170 · COMPLETED
Trial details
- NCT number
- NCT01769170
- Sponsor
- Jazz Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-12-01
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.